Silence Therapeutics plc
Ticker: 1479615
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.42+162.5% | 0.16-27.3% | 0.22+57.1% | 0.14 |
| Total Income | 0.42+162.5% | 0.16-27.3% | 0.22+57.1% | 0.14 |
| EXPENSES | ||||
| Expenditure | 16.16-38.8% | 26.40+9.1% | 24.19-15.3% | 28.55 |
| Tax | 0.00 | 0.00-100.0% | 0.01 | 0.00 |
| PROFIT | ||||
| PBT | -14.96+28.6% | -20.96+23.3% | -27.34+4.2% | -28.53 |
| Net Profit | -14.96+28.6% | -20.96+23.4% | -27.35+4.1% | -28.53 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.11+26.7% | -0.15+21.1% | -0.19+5.0% | -0.20 |
Corporate Events
Board MeetingSLN
202610Jul
Board Meeting
Disclosure of material modifications to the separation agree…
SEC Filing ↗ Board MeetingSLN
202616Jun
Board Meeting
Annual General Meeting of Shareholders to vote on the re-app…
SEC Filing ↗